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Abstract
Background—The Environment and Reproductive Health (EARTH) Study is an ongoing 
prospective preconception cohort designed to investigate the impact of environmental, nutritional, 
and lifestyle factors among both women and men on fertility and pregnancy outcomes.
Methods—The EARTH Study recruits women 18 to 45 years and men 18 to 55 years seeking 
fertility evaluation and treatment at the Massachusetts General Hospital (MGH) Fertility Center, 
Boston, USA. Women and men are eligible to join either independently or as a couple. Participants 
are followed from study entry throughout each fertility treatment cycle, once per trimester of 
pregnancy (for those achieving pregnancy), and up to labor and delivery, or until they discontinue 
treatment or withdraw from the study. The study collects biological samples, self-reported 
questionnaire data (including a food frequency questionnaire) and clinically abstracted 
information.
Results—As of June 2017, the study cohort included 799 women and 487 men (447 couples; 40 
men joined without female partners). Women were on average 34.7 years old at time of enrolment 
and predominantly Caucasian (81%), educated (49% have a graduate degree), and nulliparous 
(83%). Men were on average 36.6 years at baseline and mostly Caucasian (86%) and never-
smokers (67%).
Conclusions—The EARTH Study is one of the few cohorts designed to examine multiple 
potentially critical windows of vulnerability, including the paternal and maternal preconception 
windows and the periconception and prenatal windows in pregnancy. It is also one of the few 
human studies that has assessed potential interactions between environmental exposures and 
dietary factors.
Keywords
prospective; preconception; cohort; infertility; environmental exposures; diet; pregnancy; male and 
female reproduction
Introduction
Accumulating epidemiologic evidence over the last several decades has shown associations 
of environmental chemicals with adverse reproductive health outcomes, including male and 
female infertility, poor pregnancy outcomes, and increased risk of diseases in childhood and 
beyond (Bergman, et al., 2012, Woodruff, et al., 2008). Nutritional factors also impact 
reproductive health both directly and by modifying the potential effects of some 
environmental chemicals on these same endpoints (2006, Homan, et al., 2007, Sharpe and 
Franks, 2002). Most studies to date have been designed to examine environmental or 
nutritional factors during pregnancy on fetal and infant health but few studies have 
simultaneously assessed environmental and nutritional exposures and even fewer have 
included assessments during the preconception period. Experimental animal studies and 
limited human studies have shown that the sensitive window of exposure for fetal and infant 
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health includes the preconception period in both women and men (Braun, et al., 2017, 
Chapin, et al., 2004, Louis, et al., 2008). Investigating the maternal and paternal 
preconception period is challenging in most observational studies and requires a design that 
identifies and recruits women and men attempting pregnancy to be followed until conception 
and onward (Buck Louis, et al., 2011). Furthermore, early and sensitive reproductive 
endpoints of interest (e.g., ovarian follicle growth, fertilization, implantation, biochemical 
pregnancy loss) in relation to diet and environmental chemical exposures are largely 
unobservable in population-based designs.
In an effort to address these challenges, we established the Environment and Reproductive 
Health (EARTH) Study, an ongoing prospective preconception cohort of couples seeking 
care at the Massachusetts General Hospital (MGH) Fertility Center, to investigate 
environmental, nutritional, and lifestyle factors among both women and men in relation to 
fertility and pregnancy outcomes. The EARTH Study was designed to examine multiple 
potentially relevant periods of vulnerability, including the paternal and maternal 
preconception windows as well as the periconception and prenatal windows in pregnancy. 
The study has been funded by the National Institute of Environmental Health Sciences since 
its inception in 2004. A comprehensive assessment of diet was added in 2007. Future goals 
include following the children of the couples, as well as the mothers and fathers who 
enrolled in the EARTH Study.
Methods
Participant Eligibility and Recruitment
The EARTH Study recruits women and men seeking fertility evaluation and medically 
assisted reproductive treatment at the Massachusetts General Hospital (MGH) Fertility 
Center. Women 18 to 45 years, and men 18 to 55 years who have not had a vasectomy and 
who are not taking hormones at the time of enrollment, are eligible to join either 
independently or as a couple. The study has strong support and collaboration from 
physicians and other medical personnel from the MGH Fertility Center who identify 
potentially eligible patients in their practice and briefly inform them of the study at any point 
during their care, including at the start of their fertility investigation or after initiating 
treatment. A study staff member then approaches potential participants and further 
determines their eligibility and interest. The study staff provides each potential participant 
with complete information about the requirements and expectations of enrolling in the 
EARTH Study and answers questions. All participants agreeing to join in the study provide 
written informed consent. The study was approved by the Institutional Review Boards of 
MGH (Partners), Harvard T.H. Chan School of Public Health, and the Centers for Disease 
Control and Prevention (CDC).
Design and Follow-up
All participants enrolling in the EARTH Study are scheduled for a detailed entry visit with a 
study staff member. During this first visit, female and male participants complete a series of 
baseline questionnaires, undergo anthropometric measurements, and provide a spot urine 
and blood sample. They are also given a comprehensive self-reported questionnaire (take-
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home or online) (Figure 1). Couples trying to conceive using medically assisted 
reproduction undergo different types of treatment, including in-vitro fertilization (IVF) 
based technologies (i.e., fresh or frozen IVF protocols, including intracytoplasmic sperm 
injection) and non-IVF based treatments (i.e., intrauterine insemination (IUI), ovulation 
induction, and ovarian stimulation). Both IVF and non-IVF based treatments require careful 
and detailed cycle follow-up at the clinic. During the monitoring phase of the treatment 
cycle (approximate follicular days 3 to 9), women provide a single spot urine sample and 
non-fasting blood sample, and at the same time complete a questionnaire regarding personal 
care product use in the past 24 hours. Following the monitoring phase, on the clinic visit day 
of the scheduled fertility procedure [i.e., on day of oocyte-retrieval (for fresh IVF protocols) 
or embryo transfer (for frozen IVF protocols) or on day of IUI procedure (for non-IVF based 
cycles)], women complete another product use questionnaire and provide an additional spot 
urine sample (Figure 1). Women undergoing oocyte retrieval also provide a follicular fluid 
sample. All women are followed to determine pregnancy status after each individual 
treatment cycle, which includes a routine human chorionic gonadotropin (β-hCG) blood test 
on day 12 to 17 following the IVF or IUI procedure day. Women achieving a positive 
pregnancy test undergo an ultrasound scan at approximately gestational week 6 for clinical 
confirmation of an intrauterine pregnancy and are followed throughout the prenatal period. 
Pregnant participants provide a spot urine and non-fasting blood sample and complete a 
product use questionnaire once per trimester at approximately 6 weeks, 24 weeks, and 33 
weeks gestation (Figure 1).
In addition to the other baseline questionnaires, anthropometric measurements, blood and 
urine specimens, men provide a semen sample and complete an abstinence time 
questionnaire at enrollment if their study entry visit coincides with a routine semen sample 
collection. On the day their female partner undergoes their scheduled fertility treatment 
procedure, male participants provide another spot urine sample, non-fasting blood sample, 
and semen sample along with the abstinence time questionnaire (Figure 1). For men 
participating without their female partner, we obtain consent to release the birth and 
newborn nursery records from the delivering hospital.
Data and Biospecimen Collection
The EARTH Study prospectively collects a combination of biological samples, self-reported 
questionnaire data, and medical information abstracted from fertility clinic and delivery 
records (Table 1).
Biological Samples—The EARTH Study was designed to examine exposures across 
several windows: paternal and maternal preconception windows, and maternal 
periconception and prenatal windows. We obtain prospective repeated urine and blood 
samples at several times during these periods (Figure 1). There is also an optional voluntary 
hair sample collection. All samples were collected using methods to minimize exogenous 
contamination by known environmental chemicals (Calafat, et al., 2015). To date, we have 
collected 32,792 and 8,967 urine aliquots, and 8,156 and 3,875 blood aliquots from women 
and men, respectively. These have been archived and stored at the Harvard T.H. Chan School 
of Public Health. The CDC has quantified urinary biomarkers of >40 chemicals, including: 
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phthalates and diisononyl cyclohexane-1,2-dicarboxylate (DINCH) metabolites, phenols 
(e.g., bisphenol A, triclosan, parabens), and pesticides (metabolites of organophosphates, 
pyrethroids, 2,4-dichlorophenoxyacetic acid, and N,N-diethyl-m-toluamide). 
Organophosphate flame-retardants and polybrominated diphenyl ethers were measured at 
Duke University.
In whole blood, we have quantified heavy metals and metalloids (e.g., lead, cadmium, 
manganese) at the Mount Sinai School of Medicine in a subgroup of 150 women. We have 
measured serum folate, vitamin B12, fatty acids, and vitamin D concentrations among 100 
women. Among 558 women, we have also analyzed serum for thyroid hormones (thyroid 
stimulating hormone, free thyroxine 4 (T4), T4, free T3, T3, thyroglobulin, and 
thyroperoxidase antibodies). To date, we have quantified mercury in more than 1,200 hair 
samples. We have also analyzed more than 1200 semen samples for standard semen quality 
parameters. From participants undergoing oocyte retrieval, we have stored 6,041 follicular 
fluid aliquots and we have analyzed 147 of them from 143 women for phthalate metabolites 
and phenols. In small pilot studies, we have measured non-coding micro RNAs in semen, 
and obtained and archived amniotic fluid samples.
Self-Reported Questionnaires—Both female and male participants complete the 
Baseline Questionnaire (BQ), which includes demographic, medical history, and lifestyle 
questions (Table 1). They also complete the self-reported Full Questionnaire (FQ) with 
information on family, medical, and reproductive history, occupational history, and lifestyle 
(e.g., physical-activity, frequency of tobacco, alcohol and illicit substance use) and the Food 
Frequency Questionnaire (FFQ). Overall, 95% of women (n=759/799) and 99% of men 
(n=484/487) completed the BQ; 91% of women (n=729/799) and 77% of men (n=376/487) 
completed the FQ. The Product Use Questionnaire is administered at baseline and once per 
treatment cycle to identify recent exposure to and time since last use of common products 
including lotions, soaps, cleaning products, plastics, pesticides, smoking and secondhand 
tobacco smoke exposure, specific foods, weight loss/weight gain products, and over-the-
counter and prescription pharmaceuticals.
Diet Assessment—Diet is assessed using a previously validated self-administered FFQ 
(Rimm, et al., 1992, Yuan, et al., 2017). Participants are asked to report how often, on 
average, they consume specified amounts of the 131 foods, beverages, and supplements 
listed i n the questionnaire over the past year with 9 possible response categories ranging 
from never/almost never to ≥6 times per day. Open-ended questions are used for usual brand 
and type of margarine, cooking oil, cold breakfast cereal, and multivitamins. Intakes for over 
100 nutrients and non-nutritive food constituents are estimated by linking participant 
responses to a custom nutrient composition database maintained and updated by the 
Department of Nutrition, Harvard T H. Chan School of Public Health.
Other Environmental and Biological Samples—We have collected 240 home dust 
samples and 120 primary teeth from children of EARTH Study participants. For a small 
subset of volunteers (118 women and 52 men) we also measured electromagnetic fields 
using a portable magnetic field monitor. Recently, using couples' self-reported residential 
addresses at study entry, we collected and estimated distance to major roadway, near-
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residence traffic density, and PM2.5, BC, NO2, CO, and SO2 concentrations during each 
fertility treatment cycle.
Electronic Medical Record Abstraction – Cycle, Pregnancy, and Delivery Data
—We have an extensive clinical abstraction process to obtain prospective data during each 
individual fertility treatment cycle and throughout follow-up (up to the birth of an infant for 
those achieving pregnancy). Trained study staff abstract pertinent clinical information from 
the electronic medical records at the MGH to ascertain the outcome of each cycle, including 
mode of conception, cycle cancellation, oocyte parameters, early embryo development, 
implantation, biochemical pregnancy (with β-hCG measurements), clinical pregnancy (with 
ultrasound assessment), physician-assigned infertility diagnosis, polycystic ovarian 
syndrome, terminations, pregnancy complications and pathology, glucose tolerance tests 
during pregnancy, and delivery outcomes (e.g., livebirths, stillbirths, birth weight, gestational 
age, infant sex, complications and pathologies).
Anthropometry—At study entry, trained study staff measure and record each participant's 
height, weight, and waist circumference. Additional weight measurements taken during 
routine prenatal visits are abstracted from electronic medical records.
Child Follow-Up—Two pilot studies have been conducted on small subsets of children 
born to EARTH Study participants. In one, we measured anogenital distance in male and 
female infants at 3 to 18 months of age. In the second, we assessed behavior in 166 children 
via parent-completed mailed questionnaires adapted from the Behavior Assessment System 
for Children (BASC, 2nd edition), Social Responsiveness Scale, and Preschool Activity 




Among patients initially approached by the EARTH Study staff as of June 2017, 
approximately 65% (N=806) of women and 45% of men (n=492) were eligible and agreed 
to enroll (Figure 2). Participants are followed from study entry throughout their fertility care, 
pregnancy, and birth (for those achieving pregnancy), or until they discontinue treatment or 
withdraw from the study. During the course of follow-up, 7 women and 5 men discontinued 
treatment or withdrew. As of June 2017, the cohort included 799 women and 487 men (447 
couples; 40 men joined without female partners) (Figure 2). Women in the EARTH Study 
were on average 34.7 years old with a Body Mass Index (BMI) of 24.6 kg/m2 at time of 
enrollment (Table 2). They are predominately Caucasian (81%), highly educated (49% have 
a graduate degree), never-smokers (73%), and nulliparous (83%). Approximately one third 
of women (35%) have a female factor of infertility as their primary diagnosis. Men were on 
average 36.6 years old with a BMI of 27.5 kg/m2 at time of enrollment. Most men are 
Caucasian (86%), highly educated (41% with graduate degree), and never-smokers (67%), 
and 30% have a male factor as their primary infertility diagnosis (Table 2).
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Participants have been followed for a total of 813 IVF-based treatment cycles, 941 non-IVF 
based treatment cycles, and 151 non-medically assisted/naturally conceived cycles during 
follow-up in the EARTH Study. These 1905 initiated cycles resulted in 713 pregnancies of 
which 11% (n=76/713) were only chemically detected by a β-hCG blood test and not 
clinically visualized on ultrasound (biochemical losses). Among the remaining 637 
ultrasound-confirmed pregnancies, 19% ended in a spontaneous loss before 20 weeks 
gestation, 1% ended in a therapeutic abortion, 2% in ectopic loss, 1% ended in stillbirth (loss 
on or after 20 weeks), or were lost to follow-up during pregnancy (2%) (Figure 2). There 
have been 474 successful pregnancies resulting in 563 live births: 387 singletons and 176 
multiples (85 pairs of twins, 2 sets of triplets). Among these births, 47 females and 17 males 
were recurrent participants who returned for further treatment and delivered (or their female 
partner delivered) 1 singleton and 46 twins. The overall live birth rate per initiated cycle is 
26% (n=487/1905) and the live birth rate among cycles achieving pregnancy is 68% 
(n=487/713). Among IVF only cycles, the live birth rate per initiated cycle is 37% 
(n=299/813) and the live birth rate among cycles achieving pregnancy is 80% (n=299/375).
Key Findings
A summary of key environmental chemical, dietary, and lifestyle factor findings can be 
found in Table 3.
Environmental Chemicals—Among women in the EARTH Study undergoing assisted 
reproductive technology (ART), higher urinary concentrations of metabolites of di-(2-
ethylhexyl) phthalate (DEHP) were associated with reduced oocyte yields, lower likelihood 
of clinical pregnancy, increased risk of pregnancy loss, and lower likelihood of live birth 
following infertility treatment (Hauser, et al., 2016, Messerlian, et al., 2016). Exposure to 
certain phthalates among men was also associate with decreased odds of implantation and 
live birth (Dodge, et al., 2015). Maternal soy and folate intake significantly modified the 
association between BPA and IVF outcomes in women (Chavarro, et al., 2016, Minguez-
Alarcon, et al., 2016). We also examined whether urinary biomarkers of environmental 
chemicals were associated with antral follicle count (AFC) measured by ultrasound on day 3 
of the follicular phase of a woman's unstimulated menstrual cycle (Messerlian, et al., 2016, 
Souter, et al., 2013), or with second trimester glucose levels (Chiu, et al., 2017). Among 
men, higher monobutyl phthalate concentrations were associated with decreased semen 
quality in a dose-dependent manner (Hauser, et al., 2006).
Nutrition and Lifestyle Factors—Among women undergoing ART, we found that pre-
treatment intake of folate and vitamin B12 (Gaskins, et al., 2014, Gaskins, et al., 2015), 
whole grains (Gaskins, et al., 2016), and soy products (Vanegas, et al., 2015) were each 
independently and positively related to the probability of live birth. Maternal serum vitamin 
D levels were also positively associated with fertilization rates; however, this did not lead to 
higher probability of pregnancy or live birth (Abadia, et al., 2016). Paternal habitual caffeine 
intake was negatively associated with live birth, while maternal caffeine intake was not 
(Abadia, et al., 2017). Maternal vigorous activity prior to ART treatment was positively 
associated with probability of live birth among women of normal BMI but not among 
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overweight or obese women (Gaskins, et al., 2016). Within occupational factors, women 
who reported lifting/moving heavy objects at work had fewer total and mature oocytes, as 
well as a small reduction in mean AFC, compared with women who reported never lifting/
moving heavy objects (Minguez-Alarcon, et al., 2017).
In the EARTH Study, men's soy food intake was negatively associated with sperm 
concentration (Chavarro, et al., 2008). Saturated (Attaman, et al., 2012) and trans fatty acid 
intake was also inversely associated with sperm concentration (Chavarro, et al., 2011). Fish 
intake and omega 3 fatty acids (Attaman, Toth, Furtado, Campos, Hauser and Chavarro, 
2012) were associated with an increase in percent of morphologically normal sperm 
(Afeiche, et al., 2014), while processed meat was associated with the opposite effect 
((Afeiche, Gaskins, Williams, Toth, Wright, Tanrikut, Hauser and Chavarro, 2014). High 
pesticide residue fruit and vegetable intake was associated with lower total sperm count and 
lower morphologically normal sperm (Chiu, et al., 2015). Among the lifestyle factors 
examined, physical activity had a positive effect on sperm concentration, while a BMI ≥35 
kg/m2 was associated with lower total sperm count (Chavarro, et al., 2010). We found no 
association between mobile phone use and semen parameters in this cohort (Lewis, et al., 
2017).
Personal Care Product Use and Exposure—The EARTH Study has also identified 
determinants of environmental exposures, particularly due to personal care product use. We 
evaluated whether questionnaire-based self-reported use of personal care products predicted 
urinary biomarkers of phthalates and parabens in men (Supplementary Data, Figure S1)50 
and women (Supplementary Data, Figure S2) (Braun, et al., 2014, Nassan, et al., 2017).
Comment
The EARTH Study is one of the few cohorts to have repeated exposure measurements -
including biospecimen data from men and women from the period before conception, 
throughout attempted pregnancy cycles, and from each trimester among pregnant 
participants (see Figure 1). There are several advantages to multiple biospecimens collected 
from men and women over an extended time. First, we can identify distinct periods of 
sensitivity and account for the correlation between exposure windows and within couples. 
Second, having more than one urine or blood sample for each exposure window reduces the 
potential for exposure misclassification, particularly for chemicals with short half-lives such 
as phthalates and phenols. We are also able to study the largely unexplored pre- and peri-
conception periods as we have at least one urine sample collected from men and women 
from this window. The EARTH Study has measured more than forty different biomarkers of 
environmental chemical exposures, thus enabling us to investigate the relationships between 
mixtures of chemicals and endpoints of interest. The study is designed to assess very early 
pregnancy stages and outcomes for each attempted cycle, allowing for the evaluation of 
endpoints that are unobservable in most pregnancy cohorts. Documentation of outcomes is 
also highly accurate as it relies on clinical abstraction of cycle endpoints by trained study 
staff. We also have comprehensive covariate data collected through self-reported measures 
as well as from electronic medical records. Finally, due to the intensive collection of dietary 
data, the EARTH Study is also one of the few human studies able to assess potential 
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interactions between environmental chemicals and dietary factors, which are an important 
and emerging area of research.
While the fertility clinic setting provides the opportunity to measure environmental 
exposures across different windows of vulnerability and evaluate their potential effects on 
critical early fertility, pregnancy, and delivery outcomes, findings may be less generalizable 
to naturally conceived pregnancies (Messerlian, 2017). Pregnancies conceived to subfertile 
couples may also be more vulnerable to exposures and results may be specific to the 
population under study. However, this potential concern is outweighed by the study strengths 
– a research design that is internally valid and sufficiently powered to explore previously 
unstudied paternal and maternal exposures in relation to relevant and measurable endpoints. 
We further believe that this vulnerable population represents an important public health 
subpopulation given the growing number of babies born using IVF-based treatment, 
estimated to be 1.6% of all births or >68,000 births annually in the USA, with even higher 
proportions in certain European nations. The fraction of births using non-IVF based ART 
treatment in the USA is even higher at ∼4.6% (∼191,000 births), totaling >250,000 births 
per year in the USA (Dyer, et al., 2016, Schieve, et al., 2009, Sunderam, et al., 2017, Zegers-
Hochschild, et al., 2014).
One particular challenge, however, in studying an infertile subpopulation involves the 
complexity of disentangling the effects of underlying infertility or its treatment from the 
exposure – outcome association of interest. The study is limited by the absence of fertile 
couples as a comparison group that is unconfounded by infertility or its treatment. 
Nevertheless, we attempt to control for causes of infertility and treatment either through 
adjustment or stratification (Messerlian, et al., 2017). Analytical plans, have also relied on 
the use of directed acyclic graphs to identify potential confounders that are not causal 
intermediates between exposure and outcomes (Messerlian, 2017). Furthermore, while we 
can control for many potential confounders, we cannot adjust for some co-exposures to 
unmeasured environmental chemicals or other unknown determinants of both exposure and 
health outcomes. Lastly, while the EARTH Study has tested many a priori hypotheses, we 
have undertaken multiple comparisons and cannot rule out the possibility that some of our 
findings may be spurious or due to chance.
Where can I find out more?
The EARTH Study has collaborated with students, post-doctoral and clinical fellows and 
visiting scientists, and welcomes the opportunity for new and continued collaborations. All 
inquiries should be made to Dr. Russ Hauser, Principal Investigator, Harvard T.H. Chan 
School of Public Health (rhauser@hsph.harvard.edu). More information about the study and 
a complete list of our publications can be found at: https://www.hsph.harvard.edu/earth/
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Maternal and Paternal Assessment in the Environment and Reproductive Health 
(EARTH) Study
Female participants: Study Entry (SE) Assessment includes: baseline urine and blood 
samples, and completion of the Baseline and Full Questionnaires (includes the Food 
Frequency Questionnaire).
Treatment (Tx) Cycle (i), connotes any number of followed cycles including those treated 
with in-vitro fertilization (IVF) based technologies or non-IVF based procedures. 
Assessment at two points in time during each Treatment (Tx) Cycle: S1 - includes the first 
spot urine sample and blood sample collected during the follicular phase of the cycle (days 3 
to 9) and the completion of the Product Use Questionnaire (PQ) at the same point in time. 
S2 - includes the second spot urine sample collected at the time of scheduled treatment 
procedure (oocyte retrieval, embryo transfer or intrauterine insemination) and a follicular 
fluid sample collected during oocyte retrievals. All SE, S1, and S2 samples represent 
exposure in the maternal preconception period.
Treatment (Tx) Cycle (c) connotes the index cycle of conception. Clinical information about 
the mode of conception (IVF-based, non-IVF based, or non-medically assisted) is abstracted 
from electronic medical records by trained study staff. S1 and S2 samples collected in the 
index conception represent exposure in the maternal periconception period.
P1/P2/P3 - includes a single urine sample and blood sample and Produce Use 
Questionnaires collected in the 1st, 2nd, and 3rd trimester of pregnancy, respectively. P1, P2, 
and P3 samples collected following the index conception represent the maternal prenatal 
exposure period.
Male participants: Study Entry (SE) Assessment includes: baseline urine and blood 
samples, and completion of the Baseline and Full Questionnaires (includes the Food 
Frequency Questionnaire). Men also provide a semen sample and an abstinence time 
questionnaire at baseline if their study entry visit coincides with a routine semen sample 
collection.
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ssessment at Treatment (Tx) cycle: S1 includes a spot urine sample, blood sample, and 
semen sample along with the abstinence time questionnaire on the day their female partner 
undergoes their scheduled fertility treatment procedure. SE and S1 samples collected up to 
the index conception represent the paternal preconception exposure period.
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Figure 2. Environment and Reproductive Health (EARTH) Study Participant Flow Chart
Abbreviations: BQ: Baseline Questionnaire; FQ: Full Questionnaire (includes the Food 
Frequency Questionnaire).
Definitions: Biochemical pregnancy loss is defined as the demise of a β -hCG-confirmed 
pregnancy that was never visualized on ultrasound.
Clinical pregnancy loss is defined as the demise of an ultrasound confirmed intrauterine 
pregnancy up to 20 weeks gestation. IVF Cycles include fresh and frozen in-vitro 
fertilization-based protocols. IUI Cycles include all non-IVF based procedures such as 
intrauterine insemination, ovulation induction, and ovarian stimulation. Non-Medically 
Assisted Cycles are those that were conceived naturally without treatment.
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Table 2
Characteristics from 799 women and 487 men (447 couples) participating in the Environment and 
Reproductive Health (EARTH) Study from 2004 – 2017.
Characteristic Women N=799 Men N=487
Age (years)
Mean (SD) 34.7 (4.5) 36.6 (5.4)
Age>35, n (%) 345 (43) 273 (56)
Race, n (%)
White 651 (81) 419 (86)
Black 39 (5) 15 (3)
Asian 71 (9) 34 (7)
Other 38 (5) 19 (4)
Body Mass Index (BMI, Kg/m2)
Mean (SD) 24.6 (4.9) 27.5 (4.5)
BMI >25, n (%) 283 (35) 346 (71)
Education, n (%)
< College 60 (8) 55 (11)
College Graduate 231 (29) 136 (28)
Graduate Degree 392 (49) 198 (41)
Missing 116 (14) 98 (20)
Smoking Status, n (%)
Never 583 (73) 327 (67)
Former 192 (24) 131 (27)
Current 24 (3) 29 (6)
Primary Infertility Diagnosis, n (%)
Male Factor 196 (24) 146 (30)
Female Factor 285 (36) 166 (34)





Unexplained 318 (40) 175 (36)
Nulliparous at study entry, n (%)
698 (87) -
Live Births, n (%)
Singletons, n (%) 387/563 (69)
Multiples, n (%) 176/563 (31)
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Table 3
Key Findings in the Environment and Reproductive Health (EARTH) Study.
Studies on Endocrine Disrupting Chemicals
Study Participant EDC Key Finding Reference
Women undergoing ART DEHP Decreased oocyte yield Hauser et al., 2016 (16)
Women undergoing ART DEHP Decreased probability of clinical pregnancy Hauser et al., 2016 (16)
Women undergoing ART DEHP Decreased probability of live birth Hauser et al., 2016 (16)
Women conceiving with ART or 
non-ART
DEHP Increased pregnancy loss Messerlian et al., 2016 (17)
Men with female partner 
undergoing ART
DOP and DiNP Decreased odds of implantation Dodge et al., 2015 (18)
Men with female partner 
undergoing ART
DOP and DiNP Decreased odds of live birth Dodge et al., 2015 (18)
Women undergoing ART BPA (modification by 
soy)
Among women not consuming soy, BPA 
associated with decreased probability of 
implantation, clinical pregnancy, and live birth
Minguez-Alarcon et al., 
2016 (19)
Women undergoing ART BPA (modification by 
folate)
Among women consuming <400μg food folate/
day, BPA associated with decreased probability 
of implantation, clinical pregnancy, and live 
birth
Chavarro et al., 2016 (20)
Female EARTH Study 
participants
DEHP Decreased number of antral follicles measured 
on day 3 of an unstimulated cycle.
Messerlian et al., 2016 (21)
Female EARTH Study 
participants
BPA Decreased number of antral follicles measured 
on day 3 of an unstimulated cycle.
Souter et al., 2013 (22)
Female EARTH Study 
participants
BPA Increased maternal blood glucose levels Chiu et al., 2017 (23)
Male EARTH Study participants DnBP Decreased sperm concentration Hauser et al., 2006 (24)
Studies on Nutrition
Study Participant Dietary Factor Key Finding Reference
Women undergoing ART Folate Increased live birth rate Gaskins et al., 2014 (25)
Women undergoing ART Vitamin B12 Increased live birth rate Gaskins et al., 2015 (26)
Women undergoing ART Whole Grains Increased live birth rate Gaskins et al. 2016 (27)
Women undergoing ART Soy product Increased live birth rate Vanegas et al., 2015 (28)
Women undergoing ART Vitamin D Increased fertilization rate Abadia et al., 2016 (29)
Male EARTH Study participants Caffeine Decreased live birth rate Abadia et al., 2017 (30)
Male EARTH Study participants Soy Decreased sperm concentration Chavarro et al., 2008 (33)
Male EARTH Study participants Saturated fats Decreased sperm concentration Attaman et al., 2012 (34)
Male EARTH Study participants Trans fatty acids Decreased sperm concentration Chavarro et al., 2011 (35)
Male EARTH Study participants Fish and omega fatty 
acids
Increased percent of morphologically normal 
sperm
Attaman et al., 2012 (34)
Male EARTH Study participants Processed meat Decreased percent of morphologically normal 
sperm
Afeiche et al., 2014 (36)
Male EARTH Study participants High pesticide residue 
fruit and vegetables
Decreased total sperm count and decreased 
percent morphologically normal sperm
Chiu et al., 2015 (37)
Studies on Lifestyle Factors
Study Participant Lifestyle Factor Key Finding Reference
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Studies on Endocrine Disrupting Chemicals
Study Participant EDC Key Finding Reference
Women undergoing ART Vigorous exercise Increased live birth rate among women with 
normal BMI
Gaskins et al., 2016 (31)
Female EARTH Study 
participants
Heavy lifting/moving 
heavy objects at work
Fewer total and mature oocytes and decreased 
number of antral follicles
Minguez-Alarcon et al., 
2017 (32)
Male EARTH Study Participants Physical activity Higher sperm concentration Chavarro et al., 2010 (38)
Male EARTH Study Participants BMI Men with BMI≥35kg/m2:decreased total sperm 
count
Chavarro et al., 2010 (38)
Abbreviations: Assisted Reproductive Technology (ART); Endocrine Disrupting Chemical (EDC);di-(2-ethylhexyl) phthalate (DEHP); Di-n-octyl 
phthalate (DOP) Di-isononyl phthalate (DiNP); Di-n-butyl phthalate (DBP); Bisphenol A (BPA); Body Mass Index (BMI).
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